Literature DB >> 10438808

An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.

P A Goepfert1, K Shaw, G Wang, A Bansal, B H Edwards, M J Mulligan.   

Abstract

Among all retroviruses, foamy viruses (FVs) are unique in that they regularly mature at intracytoplasmic membranes. The envelope glycoprotein of FV encodes an endoplasmic reticulum (ER) retrieval signal, the dilysine motif (KKXX), that functions to localize the human FV (HFV) glycoprotein to the ER. This study analyzed the function of the dilysine motif in the context of infectious molecular clones of HFV that encoded mutations in the dilysine motif. Electron microscopy (EM) demonstrated virion budding both intracytoplasmically and at the plasma membrane for the wild-type and mutant viruses. Additionally, mutant viruses retained their infectivity, but viruses lacking the dilysine signal budded at the plasma membrane to a greater extent than did wild-type viruses. Interestingly, this relative increase in budding across the plasma membrane did not increase the overall release of viral particles into cell culture media as measured by protein levels in viral pellets or infectious virus titers. We conclude that the dilysine motif of HFV imposes a partial restriction on the site of viral maturation but is not necessary for viral infectivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438808      PMCID: PMC104245     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Retrovirus envelope glycoproteins.

Authors:  E Hunter; R Swanstrom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.

Authors:  R J Owens; J W Dubay; E Hunter; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.

Authors:  K Kuroki; R Russnak; D Ganem
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

Authors:  D Gheysen; E Jacobs; F de Foresta; C Thiriart; M Francotte; D Thines; M De Wilde
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.

Authors:  T Shioda; H Shibuta
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

Review 7.  The foamy viruses.

Authors:  J J Hooks; C J Gibbs
Journal:  Bacteriol Rev       Date:  1975-09

8.  The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.

Authors:  M J Mulligan; P Kumar; H X Hui; R J Owens; G D Ritter; B H Hahn; R W Compans
Journal:  AIDS Res Hum Retroviruses       Date:  1990-06       Impact factor: 2.205

9.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum.

Authors:  M R Jackson; T Nilsson; P A Peterson
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  25 in total

1.  Endogenous virus of BHK-21 cells complicates electron microscopy studies of foamy virus maturation.

Authors:  G Wang; M J Mulligan; D N Baldwin; M L Linial
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Biphasic DNA synthesis in spumaviruses.

Authors:  Olivier Delelis; Ali Saïb; Pierre Sonigo
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Identification of domains in gag important for prototypic foamy virus egress.

Authors:  Gillian S Patton; Stephen A Morris; Wayne Chung; Paul D Bieniasz; Myra O McClure
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.

Authors:  T Pietschmann; H Zentgraf; A Rethwilm; D Lindemann
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.

Authors:  A Bansal; K L Shaw; B H Edwards; P A Goepfert; M J Mulligan
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.

Authors:  A Ono; J M Orenstein; E O Freed
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles.

Authors:  Jessica L Martin; Sheng Cao; Jose O Maldonado; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

9.  Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site.

Authors:  Erik Lontok; Emily Corse; Carolyn E Machamer
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Further characterization of equine foamy virus reveals unusual features among the foamy viruses.

Authors:  Charles-Henri Lecellier; Manuel Neves; Marie-Lou Giron; Joelle Tobaly-Tapiero; Ali Saïb
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.